ABBV vs SOLV: fair value comparison
AbbVie Inc. and Solventum Corporation · Updated 2026-09-07
ABBV currently screens as fairly valued while SOLV screens as overvalued. Within Healthcare, ABBV currently sits closer to the top of our discount ranking. ABBV carries the stronger quality grade.
| ABBV | SOLV | |
|---|---|---|
| Verdict | Fairly valued | Overvalued |
| Last price | $256.46 | $91.69 |
| 12-month range | $206.60–$259.99 | $64.35–$90.95 |
| Sector rank | #83 of 113 Healthcare | #87 of 113 Healthcare |
| Quality grade | B | F |
| Leverage | Low | High |
| Margin trend | Expanding | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Fairly Valued | — |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: ABBV fair value analysis · SOLV fair value analysis